Skip Header

15 results for author:"Niikura H." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (3)

Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival.

Wong T.F., Yoshinaga K., Monma Y., Ito K., Niikura H., Nagase S., Yamamoto M., Yaegashi N.

Int. J. Gynecol. Cancer 21:1428-1435(2011) · Mapped (8)

Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer.

Yue X., Akahira J., Utsunomiya H., Miki Y., Takahashi N., Niikura H., Ito K., Sasano H., Okamura K., Yaegashi N.

Pathol. Int. 60:400-406(2010) · Mapped (8)

Molecular cloning of t(2;7)(p24.3;p14.2), a novel chromosomal translocation in myelodysplastic syndrome-derived acute myeloid leukemia.

Fujita K., Sanada M., Harada H., Mori H., Niikura H., Omine M., Inazawa J., Imoto I.

J. Hum. Genet. 54:355-359(2009) · Mapped (3)

Midkine and its clinical significance in endometrial carcinoma.

Tanabe K., Matsumoto M., Ikematsu S., Nagase S., Hatakeyama A., Takano T., Niikura H., Ito K., Kadomatsu K., Hayashi S. et al.

Cancer Sci. 99:1125-1130(2008) · Mapped (4)

Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.

Yoshinaga K., Ito K., Moriya T., Nagase S., Takano T., Niikura H., Yaegashi N., Sato Y.

Cancer Sci. 99:914-919(2008) · Mapped (2)

Expression of retinoic acid receptors in human endometrial carcinoma.

Tanabe K., Utsunomiya H., Tamura M., Niikura H., Takano T., Yoshinaga K., Nagase S., Suzuki T., Ito K., Matsumoto M. et al.

Cancer Sci. 99:267-271(2008) · Mapped (11)

Expression of organic cation transporter SLC22A16 in human epithelial ovarian cancer: a possible role of the adriamycin importer.

Ota K., Ito K., Akahira J., Sato N., Onogawa T., Moriya T., Unno M., Abe T., Niikura H., Takano T. et al.

Int. J. Gynecol. Pathol. 26:334-340(2007) · UniProtKB (1) · Mapped (2)

Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer.

Sakuma M., Akahira J., Ito K., Niikura H., Moriya T., Okamura K., Sasano H., Yaegashi N.

Cancer Sci. 98:380-386(2007) · Mapped (2)

Expression of organic cation transporter SLC22A16 in human endometria.

Sato N., Ito K., Onogawa T., Akahira J., Unno M., Abe T., Niikura H., Yaegashi N.

Int. J. Gynecol. Pathol. 26:53-60(2007) · UniProtKB (1) · Mapped (2)

14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer.

Ito K., Suzuki T., Akahira J., Sakuma M., Saitou S., Okamoto S., Niikura H., Okamura K., Yaegashi N., Sasano H. et al.

Clin. Cancer Res. 11:7384-7391(2005) · Mapped (1)

Orphan nuclear receptor DAX-1 in human endometrium and its disorders.

Saito S., Ito K., Suzuki T., Utsunomiya H., Akahira J., Sugihashi Y., Niikura H., Okamura K., Yaegashi N., Sasano H.

Cancer Sci. 96:645-652(2005) · Mapped (3)

Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.

Utsunomiya H., Ito K., Suzuki T., Kitamura T., Kaneko C., Nakata T., Niikura H., Okamura K., Yaegashi N., Sasano H.

Clin. Cancer Res. 10:5850-5856(2004) · Mapped (5)

Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.

Akahira J.I., Aoki M., Suzuki T., Moriya T., Niikura H., Ito K., Inoue S., Okamura K., Sasano H., Yaegashi N.

Br. J. Cancer 90:2197-2202(2004) · Mapped (5)

Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation.

Akahira J., Sugihashi Y., Suzuki T., Ito K., Niikura H., Moriya T., Nitta M., Okamura H., Inoue S., Sasano H. et al.

Clin. Cancer Res. 10:2687-2693(2004) · Mapped (1)

Cytogenetics, FISH and RT-PCR analysis of acute promyelocytic leukemia: structure of the fusion point in a case lacking classic t(15;17) translocation.

Fujita K., Oba R., Harada H., Mori H., Niikura H., Isoyama K., Omine M.

Leuk. Lymphoma 44:111-115(2003) · UniProtKB (2)

to top of page·

Page 1 of 1